Home/Filings/4/0001479290-19-000016
4//SEC Filing

McDowell Caryn Gordon 4

Accession 0001479290-19-000016

CIK 0001479290other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 8:54 PM ET

Size

7.0 KB

Accession

0001479290-19-000016

Insider Transaction Report

Form 4
Period: 2019-01-24
McDowell Caryn Gordon
SVP, GC & Secretary
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2019-01-24+50,00050,000 total
    Exercise: $17.23Exp: 2029-01-23Common Stock (50,000 underlying)
  • Award

    Common Stock

    2019-01-24+7,50024,318 total
Footnotes (2)
  • [F1]The shares subject to the Restricted Stock award shall vest in three (3) equal annual installments beginning from February 15, 2019, subject to Ms. McDowell's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan")) on each vesting date.
  • [F2]The shares subject to the stock option shall vest in forty-eight (48) equal monthly installments beginning from January 24, 2019, subject to Ms. McDowell's Continuous Service (as defined in the Plan) on each vesting date.

Issuer

Revance Therapeutics, Inc.

CIK 0001479290

Entity typeother

Related Parties

1
  • filerCIK 0001674232

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 8:54 PM ET
Size
7.0 KB